Novartis | Marketskapitalisme



Market Capitalization Endring Dato
AbbVie USD 326.66B 43.98B 2025-04
Alcon AG CHF 37.16B 1.27B 2025-04
Almirall EUR 2B 233.12M 2025-04
Amgen USD 155.38B 15.41B 2025-04
AstraZeneca GBP 167.65B 6.86B 2025-04
Autolus Therapeutics Ltd 625.39M 212.89M 2025-04
Bayer EUR 20.62B 1.09B 2025-04
Biogen USD 17.08B 5.2B 2025-04
Bristol-Myers Squibb USD 95.99B 28.11B 2025-04
Eli Lilly USD 706.59B 26.28B 2025-04
Fresenius EUR 21.93B 3.04B 2025-04
Fresenius Medical Care EUR 12.25B 734.92M 2025-04
Galapagos EUR 1.54B 6.5M 2025-04
Genmab DKK 82.03B 16.76B 2025-04
Gilead Sciences USD 128.49B 11.2B 2025-04
GlaxoSmithKline GBP 61.55B 1.2B 2025-04
GRIFOLS EUR 3.41B 3.07B 2025-04
Hikma Pharmaceutical GBP 4.18B 241.88M 2025-04
J&J USD 379.47B 20.18B 2025-04
Lonza CHF 38.65B 136.39M 2025-04
Merck EUR 50.52B 4.57B 2025-04
Merck USD 200.13B 25.74B 2025-04
Novartis CHF 194.25B 18.5B 2024-12
Novo Nordisk A/S 2.12T 551.23B 2024-12
Orion EUR 5.81B 1.9B 2025-04
Pfizer USD 134.94B 8.78B 2025-04
Philips EUR 23.05B 4.37B 2024-12
Regeneron Pharmaceuticals USD 62.45B 6.89B 2025-04
Sanofi EUR 115.79B 10.05B 2025-04



Novartis Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.